Home › Oral Cancer › Maryland › Baltimore
Oral Cancer clinical trials in Baltimore, MD
5 studies for Oral Cancer are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
RecruitingPhase 1
- University of Maryland/Greenebaum Cancer Center, Baltimore
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Greater Baltimore Medical Center, Baltimore
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
RecruitingPhase 2
- Greater Baltimore Medical Center, Baltimore
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
RecruitingPhase 2
- Johns Hopkins Hospital East Baltimore, Baltimore
About Oral Cancer
Oral cancer can form in the mouth or throat but usually begins in the tongue and floor of the mouth. Read about the common oral cancer symptoms.
More about Oral Cancer on MedlinePlus
Oral Cancer trials in other cities
- Atlanta, GA9 studies
- St. Louis, MO8 studies
- New York City, NY8 studies
- Chicago, IL8 studies
- Durham, NC7 studies
- Houston, TX7 studies
- Portland, OR7 studies
- Kansas City, MO7 studies
- Pittsburgh, PA7 studies
- Ann Arbor, MI7 studies
- Milwaukee, WI7 studies
- Richmond, VA7 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Pancreatic Cancer31 studies
- Colorectal Cancer31 studies
- Metastatic Cancer28 studies
- Obesity26 studies
- Bladder Cancer24 studies
- Heart Failure24 studies
- Ovarian Cancer22 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.